Welcome to the webinar today!

We are giving a few minutes for folks to join, please feel free to write in the chat box

Please type questions or comments in the chat box at anytime during the presentation

from Jason Reed: Thank you, John. Can you clarify that 3- and 6-month continuation % estimates? Is the 3-month % using a denominator of all women enrolled or just the number that returned at month 1? Same question for the 6-month %: is the denominator all women enrolled or only the number that returned at 3 months? Thanks! Jason

Did you look to see whether women who discontinued started PrEP again later?

From Mwansa: Did you find that you had to adjust your national risk screening tools, (in particular the behavioural questions); with PLM?

from Grace: Were there any efforts to engage partners of pregnant/breastfeeding women to address potential IPV/Social harm? And were there any cases of IPV reported at all?

From Chantelle Hulett: Did you have any refusal to initiative due to association of PrEP with ART from AGYW?

From Chisala: With the current challenges reported among PBFW who refuse to take malaria, anemia, FP drugs, etc don't you think that intervention to improve PrEP uptake should be based on more ecological models to explain hidden social cultural confounders that are deeply embedded in the social fabric of community, domestic politics that influence health promotions and budgets and community support?

I want to know how other countries define lost to follow up clients for PrEP. We struggle with that indicator because some will discontinue for reasons already presented by John?

From Chisala: Is sustainability guaranteed in PrEP continuation considering that your study is silent on the role of government?

With the current chllanges reported among pregnat and breasfeeding women who refuce to take malaria, anemia, family planing drugs, including demoaing drugs dont you think that intervetion to improve Perp Uptake should be based on more ecological models to explain hidden social cultural confounders that are deepley embeeded in the social fabric of community, domestic politics that influnce health promotions and budgets and communtiy support

Loooking at your study sample and comparing with the ecological differnces in which prep is provided, what ar ethe likely confounders that has public health implication did you identify

Thank you for your nice presentation, My question is about STI diseases among pregnant women while they are on PrEP. Did you see any increasing of STI disease prevalence?

was the discontinuation higher in the women between the age of 15 - 24 years in comprassion to the 25+

Does anyone on the call have examples of PrEP tools for PBFW that have worked well in your setting and/or could be shared?

noting that your stydy setting hass high ANC coverage, where is the Gap TO WARRANT provision of PreP in this sub popualtion. what is the potetnial conflict between epidemiological and clinical evidence that would affect policy

As a PreP promoter am waiting to see that tool and my concern is that we need to factor in aspects of behavior change not just non clinical risk factors, once this is incoperated in our counselling then we will be ap to the task

In the long run we need to focus our intervention around social cultural and relicious bariers aorund PrEP particulary sthrethening gound up approaces that to engage commmunty leaders men and youths.